Chi-Med begins Phase Ib/II trial of sulfatinib in US
Hutchison China MediTech (Chi-Med) has commenced a Phase Ib/II trial to evaluate the efficacy and...
Hutchison China MediTech (Chi-Med) has commenced a Phase Ib/II trial to evaluate the efficacy and...